| $385M | ||
| $337M | ||
| $100M | ||
| $87M | ||
| $82M | ||
| $62M |
Buys | $102,150 | 1 | 100 |
Sells | $0 | 0 | 0 |
| GRAVES JEFFREY A | director | 1 | $102,150 | 0 | $0 | $102,150 |
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Over the last 12 months, insiders at Integra LifeSciences Holdings Corporation have bought $102,150 and sold $0 worth of Integra LifeSciences Holdings Corporation stock.
On average, over the past 5 years, insiders at Integra LifeSciences Holdings Corporation have bought $999,322 and sold $37.77M worth of stock each year.
Highest buying activity among insiders over the last 12 months: GRAVES JEFFREY A (director) — $102,150.
The last purchase of 9,000 shares for transaction amount of $102,150 was made by GRAVES JEFFREY A (director) on 2025‑11‑05.
| 2025-11-05 | GRAVES JEFFREY A | director | 9,000 0.0109% | $11.35 | $102,150 | +6.84% | ||
| 2024-12-03 | Sale | Schwartz Eric | EVP, Chief Legal Officer & Sec | 4,070 0.0053% | $24.59 | $100,102 | -39.71% | |
| 2024-12-02 | Sale | McBreen Michael J. | EVP & President, CSS | 1,700 0.0022% | $24.16 | $41,064 | -39.52% | |
| 2024-08-19 | Sale | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | 1,191 0.0015% | $21.58 | $25,701 | -10.58% | |
| 2024-05-23 | ESSIG STUART | Exec. Chairman of the Board | 52,641 0.0668% | $28.49 | $1.5M | -21.66% | ||
| 2024-05-21 | HILL BARBARA B | director | 36,350 0.0462% | $27.40 | $995,816 | -18.24% | ||
| 2024-03-06 | Sale | DAVIS ROBERT T. JR. | EVP & President, TT | 8,348 0.0109% | $36.59 | $305,492 | -31.89% | |
| 2023-08-09 | Sale | Mosebrook Jeffrey | SVP, Fin & PAO | 1,177 0.0014% | $44.46 | $52,329 | -14.98% | |
| 2023-06-01 | Schwartz Eric | EVP, Chief Legal Officer & Sec | 2,640 0.0032% | $37.89 | $100,035 | +2.94% | ||
| 2023-06-01 | De Witte Jan | President & CEO | 7,792 0.0095% | $38.50 | $299,986 | +2.94% | ||
| 2023-03-07 | Sale | McBreen Michael J. | EVP & President, CSS | 1,843 0.0023% | $54.29 | $100,064 | -22.82% | |
| 2023-03-01 | Sale | DAVIS ROBERT T. JR. | EVP & President, TT | 1,566 0.0019% | $55.21 | $86,463 | -23.10% | |
| 2023-02-27 | Sale | Evoli Lisa | EVP & CHRO | 3,767 0.0046% | $57.00 | $214,731 | -25.87% | |
| 2022-12-08 | Sale | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | 279 0.0003% | $56.22 | $15,684 | -21.17% | |
| 2022-08-10 | Sale | Evoli Lisa | Executive Vice President &CHRO | 1,165 0.0014% | $55.81 | $65,020 | -7.17% | |
| 2022-08-05 | Sale | Murphy Raymond G. | 8,000 0.0096% | $55.78 | $446,266 | -5.84% | ||
| 2022-08-02 | Sale | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | 437 0.0005% | $56.77 | $24,811 | -5.40% | |
| 2022-06-15 | Sale | Evoli Lisa | Executive Vice President &CHRO | 900 0.0011% | $55.93 | $50,337 | -3.92% | |
| 2022-05-24 | Sale | Evoli Lisa | Executive Vice President &CHRO | 250 0.0003% | $59.85 | $14,963 | -8.85% | |
| 2022-04-04 | Sale | Coleman Glenn | Executive Vice President & COO | 6,268 0.0077% | $66.04 | $413,939 | -14.16% |
| GRAVES JEFFREY A | director | 41086 0.0527% | $543,978.64 | 1 | 0 | |
| CARUSO RICHARD E | 10 percent owner | 10291205 13.2121% | $136.26M | 1 | 12 | +23.04% |
| Tru St Partnership, L.P. | 10 percent owner | 8515930 10.933% | $112.75M | 0 | 9 | |
| SOROS GEORGE | 10 percent owner | 2725300 3.4988% | $36.08M | 0 | 17 | |
| ESSIG STUART | Exec. Chairman of the Board | 487922 0.6264% | $6.46M | 1 | 74 | <0.0001% |
| Arduini Peter J | President & CEO | 216713 0.2782% | $2.87M | 0 | 14 | |
| SULLIVAN JAMES M | director | 59604 0.0765% | $789,156.96 | 0 | 8 | |
| Schwartz Eric | EVP, Chief Legal Officer & Sec | 59511 0.0764% | $787,925.64 | 1 | 4 | +2.94% |
| McBreen Michael J. | EVP & President, CSS | 56182 0.0721% | $743,849.68 | 0 | 6 | |
| DAVIS ROBERT T. JR. | EVP & President, TT | 49893 0.0641% | $660,583.32 | 0 | 5 | |
| REUVERS DANIEL L. | CVP,PRES - CODMAN SPC SURGICAL | 42473 0.0545% | $562,342.52 | 0 | 7 | |
| Coleman Glenn | Executive Vice President & COO | 41288 0.053% | $546,653.12 | 0 | 16 | |
| Murphy Raymond G. | 40825 0.0524% | $540,523.00 | 0 | 7 | ||
| BRADLEY KEITH | director | 37065 0.0476% | $490,740.60 | 0 | 8 | |
| MOREL DONALD E JR | director | 37112 0.0476% | $491,362.88 | 2 | 0 | +6.47% |
| HILL BARBARA B | director | 36350 0.0467% | $481,274.00 | 4 | 0 | +3.52% |
| Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | 36088 0.0463% | $477,805.12 | 0 | 10 | |
| HENNEMAN JOHN B III | CorpVP, CAO | 34159 0.0439% | $452,265.16 | 0 | 54 | |
| PALTRIDGE ROBERT D | Corp VP, Pres. Extrem Recon | 33590 0.0431% | $444,731.60 | 0 | 4 | |
| SCHADE CHRISTIAN S | director | 32633 0.0419% | $432,060.92 | 0 | 4 | |
| GORELICK RICHARD D. | Corp VP, Gen Counsel & Sec | 21565 0.0277% | $285,520.60 | 0 | 6 | |
| NOCIOLO DON R | Senior VP, Operations | 18984 0.0244% | $251,348.16 | 0 | 7 | |
| Evoli Lisa | EVP & CHRO | 18605 0.0239% | $246,330.20 | 0 | 12 | |
| MOORADIAN JOHN | Corp VP, Global Ops & Supp Chn | 15410 0.0198% | $204,028.40 | 0 | 5 | |
| De Witte Jan | President & CEO | 12798 0.0164% | $169,445.52 | 1 | 0 | +2.94% |
| Burhop Kenneth | CORPVP,CHIEFSCIENTIFIC OFFICER | 12465 0.016% | $165,036.60 | 0 | 1 | |
| HOLTZ DAVID B | Senior VP, Finance (1) | 10248 0.0132% | $135,683.52 | 0 | 6 | |
| LEONETTI DEBORAH A | Corp VP, Glbl Servs & Repair | 8715 0.0112% | $115,386.60 | 0 | 11 | |
| Corbin Jerry E | Corp VP & Corporate Controller | 8677 0.0111% | $114,883.48 | 0 | 4 | |
| VINHAIS JOSEPH | Corp VP,Quality&Transformation | 8231 0.0106% | $108,978.44 | 0 | 4 | |
| CARLOZZI GERARD S | Executive Vice President & COO | 7813 0.01% | $103,444.12 | 0 | 21 | |
| OGRADY JUDITH | CorpVP,Reg.Affairs,CorpCompli | 7206 0.0093% | $95,407.44 | 0 | 41 | |
| LARKIN BRIAN | Corp VP, Pres.Gbl Spine &Ortho | 7069 0.0091% | $93,593.56 | 0 | 4 | |
| Ballintyn Rhonda Germany | director | 3665 0.0047% | $48,524.60 | 1 | 0 | +3.09% |
| MOSZKOWSKI NEAL | director | 3511 0.0045% | $46,485.64 | 0 | 2 | |
| VANLENT ANNE | director | 3478 0.0045% | $46,048.72 | 0 | 1 | |
| PIERSHBACHER MICHAEL | Senior V.P.., R&D | 0 0% | $0 | 0 | 4 |
| Increased Positions | 98 | +36.43% | 6M | +7.72% |
| Decreased Positions | 119 | -44.24% | 6M | -8.71% |
| New Positions | 31 | New | 1M | New |
| Sold Out Positions | 39 | Sold Out | 2M | Sold Out |
| Total Postitions | 248 | -7.81% | 74M | -0.98% |
| Blackrock, Inc. | $134,207.00 | 13.11% | 10.23M | -122,569 | -1.18% | 2025-09-30 |
| Rubric Capital Management Lp | $100,420.00 | 9.81% | 7.65M | +300,000 | +4.08% | 2025-09-30 |
| Vanguard Group Inc | $96,814.00 | 9.46% | 7.38M | -199,166 | -2.63% | 2025-09-30 |
| Fuller & Thaler Asset Management, Inc. | $51,357.00 | 5.02% | 3.91M | +21,906 | +0.56% | 2025-09-30 |
| Morgan Stanley | $50,180.00 | 4.9% | 3.82M | -109,347 | -2.78% | 2025-09-30 |
| Invesco Ltd. | $45,801.00 | 4.48% | 3.49M | -46,299 | -1.31% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $41,784.00 | 4.08% | 3.18M | +267,134 | +9.16% | 2025-09-30 |
| State Street Corp | $36,617.00 | 3.58% | 2.79M | -35,567 | -1.26% | 2025-09-30 |
| Paradigm Capital Management Inc/Ny | $33,191.00 | 3.24% | 2.53M | +348,300 | +15.97% | 2025-09-30 |
| Geode Capital Management, Llc | $20,313.00 | 1.99% | 1.55M | -94,331 | -5.74% | 2025-09-30 |